Cargando…

Hepatitis B Virus Pre-S Mutants as Biomarkers and Targets for the Development and Recurrence of Hepatocellular Carcinoma

Chronic hepatitis B virus (HBV) infection is a major risk factor for the development of hepatocellular carcinoma (HCC), the leading cause of cancer-related death worldwide. Despite progress in the prevention and therapy of HCC, high incidence and recurrence rates of HCC remain big threats, resulting...

Descripción completa

Detalles Bibliográficos
Autores principales:	Teng, Chiao-Fang, Wu, Han-Chieh, Su, Ih-Jen, Jeng, Long-Bin
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2020
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7552003/ https://www.ncbi.nlm.nih.gov/pubmed/32859114 http://dx.doi.org/10.3390/v12090945

Ejemplares similares

Approaches for Detection of Hepatitis B Virus Pre-S Gene Deletions and Pre-S Deleted Proteins and Their Application in Prediction of Higher Risk of Hepatocellular Carcinoma Development and Recurrence
por: Lin, Yueh-Te, et al.
Publicado: (2022)

Next-Generation Sequencing-Based Quantitative Detection of Hepatitis B Virus Pre-S Mutants in Plasma Predicts Hepatocellular Carcinoma Recurrence
por: Teng, Chiao-Fang, et al.
Publicado: (2020)

Increased Expression of Programmed Death Ligand 1 in Hepatocellular Carcinoma of Patients with Hepatitis B Virus Pre-S2 Mutant
por: Teng, Chiao-Fang, et al.
Publicado: (2020)

Hepatitis B Virus Pre-S Gene Deletions and Pre-S Deleted Proteins: Clinical and Molecular Implications in Hepatocellular Carcinoma
por: Lin, Yueh-Te, et al.
Publicado: (2021)

A Next-Generation Sequencing-Based Platform for Quantitative Detection of Hepatitis B Virus Pre-S Mutants in Plasma of Hepatocellular Carcinoma Patients
por: Teng, Chiao-Fang, et al.
Publicado: (2018)

Increased infiltration of regulatory T cells in hepatocellular carcinoma of patients with hepatitis B virus pre-S2 mutant
por: Teng, Chiao-Fang, et al.
Publicado: (2021)

Hepatitis B virus pre-S2 deletion (nucleotide 1 to 54) in plasma predicts recurrence of hepatocellular carcinoma after curative surgical resection
por: Teng, Chiao-Fang, et al.
Publicado: (2020)

Detection of hepatitis B virus pre-S mutants in plasma by a next-generation sequencing-based platform determines their patterns in liver tissues
por: Teng, Chiao-Fang, et al.
Publicado: (2020)

Association of Low Serum Albumin Level with Higher Hepatocellular Carcinoma Recurrence in Patients with Hepatitis B Virus Pre-S2 Mutant after Curative Surgical Resection
por: Jeng, Long-Bin, et al.
Publicado: (2021)

The emerging role of hepatitis B virus Pre-S2 deletion mutant proteins in HBV tumorigenesis
por: Su, Ih-Jen, et al.
Publicado: (2014)

Association of Increased Programmed Death Ligand 1 Expression and Regulatory T Cells Infiltration with Higher Hepatocellular Carcinoma Recurrence in Patients with Hepatitis B Virus Pre-S2 Mutant after Curative Surgical Resection
por: Jeng, Long-Bin, et al.
Publicado: (2022)

Hepatitis B Virus Pre-S2 Mutant Induces Aerobic Glycolysis through Mammalian Target of Rapamycin Signal Cascade
por: Teng, Chiao-Fang, et al.
Publicado: (2015)

Chemopreventive Effect of Phytosomal Curcumin on Hepatitis B Virus-Related Hepatocellular Carcinoma in A Transgenic Mouse Model
por: Teng, Chiao-Fang, et al.
Publicado: (2019)

Combination of Hepatitis B Virus Pre-S2 Gene Deletion Mutation and Tumor-Node-Metastasis Stage Predicts Higher Hepatocellular Carcinoma Recurrence after Curative Surgical Resection
por: Jeng, Long-Bin, et al.
Publicado: (2023)

Liver regeneration accelerates hepatitis B virus‐related tumorigenesis of hepatocellular carcinoma
por: Teng, Chiao‐Fang, et al.
Publicado: (2018)

Prognostic Significance of Serum Albumin Level and Albumin-Based Mono- and Combination Biomarkers in Patients with Hepatocellular Carcinoma
por: Jeng, Long-Bin, et al.
Publicado: (2023)

Roles of conventional and complementary therapies in recurrent hepatocellular carcinoma
por: Lai, Hsiang-Chun, et al.
Publicado: (2023)

Associations Between Hepatitis B Virus Genotype and Mutants and the Risk of Hepatocellular Carcinoma
por: Yang, Hwai-I, et al.
Publicado: (2008)

A pre-S gene chip to detect pre-S deletions in hepatitis B virus large surface antigen as a predictive marker for hepatoma risk in chronic hepatitis B virus carriers
por: Shen, Fan-Ching, et al.
Publicado: (2009)

Induction of Bcl-2 Expression by Hepatitis B Virus Pre-S2 Mutant Large Surface Protein Resistance to 5-Fluorouracil Treatment in Huh-7 Cells
por: Hung, Jui-Hsiang, et al.
Publicado: (2011)

Viral Biomarkers for Hepatitis B Virus-Related Hepatocellular Carcinoma Occurrence and Recurrence
por: Liu, Yuanyuan, et al.
Publicado: (2021)

Nucleotide variants in hepatitis B virus preS region predict the recurrence of hepatocellular carcinoma
por: Chen, Xi, et al.
Publicado: (2021)

Dendritic-Cell-Vaccine-Based Immunotherapy for Hepatocellular Carcinoma: Clinical Trials and Recent Preclinical Studies
por: Jeng, Long-Bin, et al.
Publicado: (2022)

Pre-S deletions of hepatitis B virus predict recurrence of hepatocellular carcinoma after curative resection
por: Li-Shuai, Qu, et al.
Publicado: (2017)

SOX4 as biomarker in hepatitis B virus-associated hepatocellular carcinoma
por: Huang, Jian-Lv, et al.
Publicado: (2021)

Hepatitis B virus PreS2-mutant large surface antigen activates store-operated calcium entry and promotes chromosome instability
por: Yen, Tim Ting-Chung, et al.
Publicado: (2016)

Autophagy Suppresses Tumorigenesis of Hepatitis B Virus-Associated Hepatocellular Carcinoma Through Degradation of MicroRNA-224
por: Lan, Sheng-Hui, et al.
Publicado: (2014)

Recurrence-associated pathways in hepatitis B virus-positive hepatocellular carcinoma
por: Kim, Bu-Yeo, et al.
Publicado: (2015)

Functional analysis of hepatitis B virus pre-s deletion variants associated with hepatocellular carcinoma
por: Lin, Chih-Ming, et al.
Publicado: (2012)

Comprehensive investigation of key biomarkers and pathways in hepatitis B virus-related hepatocellular carcinoma
por: Liao, Xiwen, et al.
Publicado: (2019)

Resistance of ground glass hepatocytes to oral antivirals in chronic hepatitis B patients and implication for the development of hepatocellular carcinoma
por: Tsai, Hung-Wen, et al.
Publicado: (2016)

The Effects and Underlying Mechanisms of Hepatitis B Virus X Gene Mutants on the Development of Hepatocellular Carcinoma
por: Pu, Rui, et al.
Publicado: (2022)

The Relationship Between Serum Interleukin-6 and the Recurrence of Hepatitis B Virus Related Hepatocellular Carcinoma after Curative Resection
por: Sheng, Tao, et al.
Publicado: (2015)

Combination therapy with dendritic cell vaccine and programmed death ligand 1 immune checkpoint inhibitor for hepatocellular carcinoma in an orthotopic mouse model
por: Teng, Chiao-Fang, et al.
Publicado: (2020)

The Influence of Hepatitis B Viral Load and Pre-S Deletion Mutations on Post-Operative Recurrence of Hepatocellular Carcinoma and the Tertiary Preventive Effects by Anti-Viral Therapy
por: Su, Chien-Wei, et al.
Publicado: (2013)

Correction notice to “Combination therapy with dendritic cell vaccine and programmed death ligand 1 immune checkpoint inhibitor for hepatocellular carcinoma in an orthotopic mouse model”
por: Teng, Chiao-Fang, et al.
Publicado: (2021)

Metronomic Celecoxib Therapy in Clinically Available Dosage Ablates Hepatocellular Carcinoma via Suppressing Cell Invasion, Growth, and Stemness in Pre-Clinical Models
por: Yeh, Chun-Chieh, et al.
Publicado: (2020)

Association of Hepatitis B Virus Pre-S Deletions with the Development of Hepatocellular Carcinoma in Qidong, China
por: Qu, Li-Shuai, et al.
Publicado: (2014)

Evolutionary Changes of Hepatitis B Virus Pre-S Mutations Prior to Development of Hepatocellular Carcinoma
por: Zhang, An-Ye, et al.
Publicado: (2015)

Associations between Pre-S Deletion Mutation of Hepatitis B Virus and Risk of Hepatocellular Carcinoma in the Asian Population: A Meta-Analysis
por: Wang, Chao, et al.
Publicado: (2015)

Cannot write session to /tmp/vufind_sessions/sess_bb08boii7l2j10c0ackqq5msv7